BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32976875)

  • 1. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.
    de Jong R; Visser J; van Wieringen N; Wiersma J; Geijsen D; Bel A
    Radiat Oncol; 2021 Jul; 16(1):136. PubMed ID: 34301300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study.
    Ingle M; White I; Chick J; Stankiewicz H; Mitchell A; Barnes H; Herbert T; Nill S; Oelfke U; Huddart R; Ng-Cheng-Hin B; Hafeez S; Lalondrelle S; Dunlop A; Bhide S
    Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e135-e142. PubMed ID: 36336579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
    Boekhoff MR; Bouwmans R; Doornaert PAH; Intven MPW; Lagendijk JJW; van Lier ALHMW; Rasing MJA; van de Ven S; Meijer GJ; Mook S
    Clin Transl Radiat Oncol; 2022 May; 34():82-89. PubMed ID: 35372703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
    Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
    Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning target volume margin assessment for online adaptive MR-guided dose-escalation in rectal cancer on a 1.5 T MR-Linac.
    Eijkelenkamp H; Boekhoff MR; Verweij ME; Peters FP; Meijer GJ; Intven MPW
    Radiother Oncol; 2021 Sep; 162():150-155. PubMed ID: 34280404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac.
    Chen X; Ahunbay E; Paulson ES; Chen G; Li XA
    J Appl Clin Med Phys; 2020 Jan; 21(1):205-212. PubMed ID: 31799753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.
    Acharya S; Fischer-Valuck BW; Kashani R; Parikh P; Yang D; Zhao T; Green O; Wooten O; Li HH; Hu Y; Rodriguez V; Olsen L; Robinson C; Michalski J; Mutic S; Olsen J
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):394-403. PubMed ID: 26678659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
    Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
    Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer.
    Kensen CM; Janssen TM; Betgen A; Wiersema L; Peters FP; Remeijer P; Marijnen CAM; van der Heide UA
    Radiat Oncol; 2022 Jun; 17(1):110. PubMed ID: 35729587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
    Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
    Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.
    Gao LR; Tian Y; Wang MS; Xia WL; Qin SR; Song YW; Wang SL; Tang Y; Fang H; Tang Y; Qi SN; Yan LL; Liu YP; Jing H; Chen B; Xing NZ; Li YX; Lu NN
    Front Oncol; 2023; 13():1039901. PubMed ID: 36741014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for radiotherapy dose escalation in rectal cancer using online MR-guidance and rectal ultrasound gel filling - Rationale and first in human.
    Gani C; Lo Russo M; Boeke S; Wegener D; Gatidis S; Butzer S; Boldt J; Mönnich D; Thorwarth D; Nikolaou K; Zips D; Nachbar M
    Radiother Oncol; 2021 Nov; 164():37-42. PubMed ID: 34534612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
    Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis.
    Boekhoff MR; Defize IL; Borggreve AS; van Hillegersberg R; Kotte ANTJ; Lagendijk JJW; van Lier ALHMW; Ruurda JP; Takahashi N; Mook S; Meijer GJ
    Radiother Oncol; 2021 Aug; 161():16-22. PubMed ID: 33992628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac.
    de Muinck Keizer DM; Kerkmeijer LGW; Willigenburg T; van Lier ALHMW; Hartogh MDD; van der Voort van Zyp JRN; de Groot-van Breugel EN; Raaymakers BW; Lagendijk JJW; de Boer JCJ
    Radiother Oncol; 2020 Oct; 151():88-94. PubMed ID: 32622779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al.
    Engels B; Gevaert T; De Ridder M
    Radiother Oncol; 2021 May; 158():244-245. PubMed ID: 33691186
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy.
    Bainbridge HE; Menten MJ; Fast MF; Nill S; Oelfke U; McDonald F
    Radiother Oncol; 2017 Nov; 125(2):280-285. PubMed ID: 28987747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.